Zobrazeno 1 - 10
of 8 073
pro vyhledávání: '"Munshi N."'
Autor:
Munshi N
Publikováno v:
Advances in Medical Education and Practice, Vol Volume 15, Pp 649-657 (2024)
Nabeel Munshi Oral and Maxillofacial Prosthodontics Department, King Abdulaziz University, Faculty of Dentistry, Jeddah, Saudi ArabiaCorrespondence: Nabeel Munshi, Oral and Maxillofacial Prosthodontics Department, King Abdulaziz University Faculty of
Externí odkaz:
https://doaj.org/article/42c71e5c750348c5a739c7f78c43e3dc
Autor:
Laplace, T. A., Goldblum, B. L., Brown, J. A., Bleuel, D. L., Brand, C. A., Gabella, G., Jordan, T., Moore, C., Munshi, N., Sweger, Z. W., Ureche, A., Brubaker, E.
Publikováno v:
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 954 (2020): 161444
Compact neutron imagers using double-scatter kinematic reconstruction are being designed for localization and characterization of special nuclear material. These neutron imaging systems rely on scintillators with a rapid prompt temporal response as t
Externí odkaz:
http://arxiv.org/abs/2009.07217
Autor:
Chung DJ, Shah N, Wu J, Logan B, Bisharat L, Callander N, Cheloni G, Anderson K, Chodon T, Dhakal B, Devine S, Dutt PS, Efebera Y, Geller N, Ghiasuddin H, Hematti P, Holmberg L, Howard A, Johnson B, Karagkouni D, Lazarus HM, Malek E, McCarthy P, McKenna D, Mendizabal A, Nooka A, Munshi N, O'Donnell L, Patel K, Rapoport AP, Reese J, Rosenblatt J, Soiffer R, Stroopinsky D, Uhl L, Vlachos IS, Waller EK, Young JW, Pasquini MC, Avigan D
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4542.
Autor:
Yao Y; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, China; The Affiliated Hospital of Xuzhou Medical University, Xuzhou., Deng S; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020., Ng JF; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Yuan M; Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou., Chakraborty C; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., JoyWeiler V; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Munshi N; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; VA Boston Healthcare System, Boston, MA., Fulciniti M; Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. mariateresa_fulciniti@dfci.harvard.edu.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 25. Date of Electronic Publication: 2024 Jul 25.
Autor:
Szalat R; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA. raphael.szalat@bmc.org., Anderson K; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA., Munshi N; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
Publikováno v:
Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2049-2059. Date of Electronic Publication: 2024 Jul 01.
Autor:
Letouzé E; Nantes Université, INSERM, CNRS, Université d'Angers, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, Nantes, France.; University Hospital Hôtel-Dieu, Nantes, France., Moreau P; Nantes Université, INSERM, CNRS, Université d'Angers, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, Nantes, France.; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France., Munshi N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA., Samur M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Veterans Affairs Boston Healthcare System, Boston, MA., Minvielle S; Nantes Université, INSERM, CNRS, Université d'Angers, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, Nantes, France.; University Hospital Hôtel-Dieu, Nantes, France., Touzeau C; Nantes Université, INSERM, CNRS, Université d'Angers, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, Nantes, France.; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.
Publikováno v:
Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2952-2959.
Autor:
O'Donnell E; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: elizabeth_odonnell@dfci.harvard.edu., Mo C; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Yee AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Laubach J; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Munshi N; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Midha S; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Cirstea D; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Chrysafi P; Mount Auburn Hospital, Cambridge, MA, USA., Horick N; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Raje N; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Jun; Vol. 11 (6), pp. e415-e424. Date of Electronic Publication: 2024 Apr 24.
Autor:
Kulkarni SS; HOD, Intensive Care Unit, Ruby Hall Clinic, Wanowrie, Maharashtra, India, Corresponding Author., Wadia RS; Consultant Neurologist, Department of Medicine, Ruby Hall Clinic, Pune, Maharashtra, India., Kharawade D; Registrar Medicine, Department of Medicine, Ruby Hall Clinic, Pune, Maharashtra, India., Nandedkar M; Consultant Microbiologist, Department of Microbiology and Pathology, Ruby Hall Clinic, Pune, Maharashtra, India., Munshi N; Director Pathology Lab, Department of Microbiology and Pathology, Ruby Hall Clinic, Pune, Maharashtra, India., Sathe P; Director ICU, Department of Intensive Care Unit, Ruby Hall Clinic, Pune, Maharashtra, India.
Publikováno v:
The Journal of the Association of Physicians of India [J Assoc Physicians India] 2024 Jun; Vol. 72 (6), pp. 99-102.
Autor:
Grasedieck S; Department of Microbiology and Immunology, University of British Columbia, 2125 East Mall, Vancouver, BC, Canada., Panahi A; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Jarvis MC; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, NC, USA., Borzooee F; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, BC, Canada., Harris RS; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Larijani M; Department of Molecular Biology and Biochemistry, Faculty of Science, Simon Fraser University, Burnaby, BC, Canada., Avet-Loiseau H; IUCT-Oncopole Toulouse, Toulouse, France., Samur M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Munshi N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Song K; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, BC Cancer, Vancouver, BC, Canada., Rouhi A; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Kuchenbauer F; Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada. fkuchenbauer@bccrc.ca.; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, BC Cancer, Vancouver, BC, Canada. fkuchenbauer@bccrc.ca.
Publikováno v:
Leukemia [Leukemia] 2024 May; Vol. 38 (5), pp. 1172-1177. Date of Electronic Publication: 2024 Mar 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.